Literature DB >> 7588844

Sternotomy infection due to Mycoplasma hominis and Ureaplasma urealyticum.

C Pigrau1, B Almirante, I Gasser, A Pahissa.   

Abstract

Mycoplasma hominis infections outside the urogenital tract are uncommon. An unusual case of sternal infection caused by both Mycoplasma hominis and Ureaplasma urealyticum is described. This is the first report found in the literature of mixed infection due to these microorganisms at this site. The outcome was favourable after drainage of the surgical wound and antibiotic therapy with clindamycin, gentamicin and doxycycline.

Entities:  

Mesh：

Year:  1995        PMID： 7588844     DOI： 10.1007/BF01690731

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  11 in total

1.  Peritonitis due to Mycoplasma hominis and Ureaplasma urealyticum in a liver transplant recipient.

Authors:  M Haller; H Forst; G Ruckdeschel; H Denecke; K Peter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

2.  Mycoplasma hominis surgical wound infection: a case report and discussion.

Authors:  M E Wilson; C Dietze
Journal:  Surgery       Date:  1988-02       Impact factor: 3.982

3.  Peritonitis due to Mycoplasma hominis in a renal transplant recipient.

Authors:  J E Mokhbat; P K Peterson; L D Sabath; J A Robertson
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

4.  Septic arthritis due to Mycoplasma hominis.

Authors:  M I McDonald; J O Moore; J M Harrelson; C P Browning; H A Gallis
Journal:  Arthritis Rheum       Date:  1983-08

Review 5.  Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression.

Authors:  R D Meyer; W Clough
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

6.  Sternotomy infections with Mycoplasma hominis.

Authors:  D O Steffenson; J S Dummer; M S Granick; A W Pasculle; B P Griffith; G H Cassell
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

7.  Mediastinitis after cardiovascular surgery.

Authors:  D H Bor; R M Rose; J F Modlin; R Weintraub; G H Friedland
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

8.  Septic arthritis due to dual infection with Mycoplasma hominis and Ureaplasma urealyticum.

Authors:  D R Burdge; G D Reid; C E Reeve; J A Robertson; G W Stemke; W R Bowie
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

Review 9.  Nongenitourinary infections caused by Mycoplasma hominis in adults.

Authors:  S Madoff; D C Hooper
Journal:  Rev Infect Dis       Date:  1988 May-Jun

10.  Extragenital Mycoplasma hominis infections in adults.

Authors:  D K McMahon; J S Dummer; A W Pasculle; G Cassell
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965
View more
  5 in total

1.  Mycoplasma hominis osteitis in an immunocompetent man.

Authors:  F Méchaï; G Le Moal; S Duchêne; C Burucoa; C Godet; M Freslon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

2.  Isolation of Mycoplasma hominis from a brain abscess.

Authors:  X Zheng; D A Olson; J G Tully; H L Watson; G H Cassell; D R Gustafson; K A Svien; T F Smith
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

Review 3.  Spontaneous bacterial pericarditis with tamponade due to Ureaplasma spp.

Authors:  William P Tarrant; Jose M Gonzalez-Berjon; Patricia L Cernoch; Randall J Olsen; James M Musser
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

4.  Ureaplasma parvum as a cause of sternal wound infection.

Authors:  Andrew Walkty; Evelyn Lo; Kanchana Manickam; Michelle Alfa; Li Xiao; Ken Waites
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

Review 5.  Ureaplasma parvum meningitis following atypical choroid plexus papilloma resection in an adult patient: a case report and literature review.

Authors:  Na Xing; Zhenxiang Zhao; Qingjing Li; Yalan Dong; Jianfeng Li; Shuping Zhang
Journal:  BMC Infect Dis       Date:  2021-12-20       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.